Cormorant Asset Management, LP Y M Abs Therapeutics, Inc. Transaction History
Cormorant Asset Management, LP
- $1.3 Billion
- Q2 2024
A detailed history of Cormorant Asset Management, LP transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Cormorant Asset Management, LP holds 1,450,000 shares of YMAB stock, worth $21.4 Million. This represents 1.35% of its overall portfolio holdings.
Number of Shares
1,450,000Holding current value
$21.4 Million% of portfolio
1.35%Shares
16 transactions
Others Institutions Holding YMAB
# of Institutions
101Shares Held
23.9MCall Options Held
19.4KPut Options Held
300-
Paradigm Biocapital Advisors LP New York, NY3.87MShares$57.1 Million1.89% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$43.3 Million0.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.19MShares$32.3 Million1.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.96MShares$28.9 Million0.0% of portfolio
-
Polar Capital Holdings PLC London, X01.83MShares$27 Million0.13% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $644M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...